- Home
- MODV vs QTTB Comparison
MODV vs QTTB Comparison
Compare MODV & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- QTTB
- Stock Information
- Founded
- MODV 1996
- QTTB 2015
- Country
- MODV United States
- QTTB United States
- Employees
- MODV N/A
- QTTB N/A
- Industry
- MODV Transportation Services
- QTTB Biotechnology: Pharmaceutical Preparations
- Sector
- MODV Consumer Discretionary
- QTTB Health Care
- Exchange
- MODV Nasdaq
- QTTB Nasdaq
- Market Cap
- MODV 16.1M
- QTTB 19.0M
- IPO Year
- MODV N/A
- QTTB N/A
- Fundamental
- Price
- MODV $1.76
- QTTB $1.85
- Analyst Decision
- MODV Buy
- QTTB Hold
- Analyst Count
- MODV 4
- QTTB 8
- Target Price
- MODV $9.17
- QTTB $24.00
- AVG Volume (30 Days)
- MODV 1.7M
- QTTB 96.6K
- Earning Date
- MODV 05-08-2025
- QTTB 05-08-2025
- Dividend Yield
- MODV N/A
- QTTB N/A
- EPS Growth
- MODV N/A
- QTTB N/A
- EPS
- MODV N/A
- QTTB N/A
- Revenue
- MODV $2,753,789,000.00
- QTTB N/A
- Revenue This Year
- MODV N/A
- QTTB N/A
- Revenue Next Year
- MODV $5.20
- QTTB N/A
- P/E Ratio
- MODV N/A
- QTTB N/A
- Revenue Growth
- MODV N/A
- QTTB N/A
- 52 Week Low
- MODV $0.87
- QTTB $1.38
- 52 Week High
- MODV $32.82
- QTTB $53.79
- Technical
- Relative Strength Index (RSI)
- MODV 55.33
- QTTB 51.11
- Support Level
- MODV $1.07
- QTTB $1.56
- Resistance Level
- MODV $1.55
- QTTB $1.96
- Average True Range (ATR)
- MODV 0.19
- QTTB 0.14
- MACD
- MODV 0.06
- QTTB 0.02
- Stochastic Oscillator
- MODV 70.40
- QTTB 51.25
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.
About QTTB Q32 Bio Inc. Common Stock
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.